Global Molecular Residual Disease Detection Market 2023 by Company, Regions, Type and Application, Forecast to 2029

1 Market Overview

• 1.1 Product Overview and Scope of Molecular Residual Disease Detection
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Molecular Residual Disease Detection by Type
  • 1.3.1 Overview: Global Molecular Residual Disease Detection Market Size by Type: 2018 Versus 2022 Versus 2029
  • 1.3.2 Global Molecular Residual Disease Detection Consumption Value Market Share by Type in 2022
  • 1.3.3 Tumor-informed Assays
  • 1.3.4 Tumor-agnostic Assays
• 1.4 Global Molecular Residual Disease Detection Market by Application
  • 1.4.1 Overview: Global Molecular Residual Disease Detection Market Size by Application: 2018 Versus 2022 Versus 2029
  • 1.4.2 Prognosis
  • 1.4.3 Adjuvant Treatment Decision-Making
  • 1.4.4 Surveillance for Postoperative Recurrence
  • 1.4.5 Other
• 1.5 Global Molecular Residual Disease Detection Market Size & Forecast
• 1.6 Global Molecular Residual Disease Detection Market Size and Forecast by Region
  • 1.6.1 Global Molecular Residual Disease Detection Market Size by Region: 2018 VS 2022 VS 2029
  • 1.6.2 Global Molecular Residual Disease Detection Market Size by Region, (2018-2029)
  • 1.6.3 North America Molecular Residual Disease Detection Market Size and Prospect (2018-2029)
  • 1.6.4 Europe Molecular Residual Disease Detection Market Size and Prospect (2018-2029)
  • 1.6.5 Asia-Pacific Molecular Residual Disease Detection Market Size and Prospect (2018-2029)
  • 1.6.6 South America Molecular Residual Disease Detection Market Size and Prospect (2018-2029)
  • 1.6.7 Middle East and Africa Molecular Residual Disease Detection Market Size and Prospect (2018-2029)

2 Company Profiles

• 2.1 Adaptive
  • 2.1.1 Adaptive Details
  • 2.1.2 Adaptive Major Business
  • 2.1.3 Adaptive Molecular Residual Disease Detection Product and Solutions
  • 2.1.4 Adaptive Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
  • 2.1.5 Adaptive Recent Developments and Future Plans
• 2.2 Guardant Health
  • 2.2.1 Guardant Health Details
  • 2.2.2 Guardant Health Major Business
  • 2.2.3 Guardant Health Molecular Residual Disease Detection Product and Solutions
  • 2.2.4 Guardant Health Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
  • 2.2.5 Guardant Health Recent Developments and Future Plans
• 2.3 Invitae
  • 2.3.1 Invitae Details
  • 2.3.2 Invitae Major Business
  • 2.3.3 Invitae Molecular Residual Disease Detection Product and Solutions
  • 2.3.4 Invitae Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
  • 2.3.5 Invitae Recent Developments and Future Plans
• 2.4 Cergentis B.V
  • 2.4.1 Cergentis B.V Details
  • 2.4.2 Cergentis B.V Major Business
  • 2.4.3 Cergentis B.V Molecular Residual Disease Detection Product and Solutions
  • 2.4.4 Cergentis B.V Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
  • 2.4.5 Cergentis B.V Recent Developments and Future Plans
• 2.5 LexentBio
  • 2.5.1 LexentBio Details
  • 2.5.2 LexentBio Major Business
  • 2.5.3 LexentBio Molecular Residual Disease Detection Product and Solutions
  • 2.5.4 LexentBio Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
  • 2.5.5 LexentBio Recent Developments and Future Plans
• 2.6 Natera
  • 2.6.1 Natera Details
  • 2.6.2 Natera Major Business
  • 2.6.3 Natera Molecular Residual Disease Detection Product and Solutions
  • 2.6.4 Natera Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
  • 2.6.5 Natera Recent Developments and Future Plans
• 2.7 BGI
  • 2.7.1 BGI Details
  • 2.7.2 BGI Major Business
  • 2.7.3 BGI Molecular Residual Disease Detection Product and Solutions
  • 2.7.4 BGI Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
  • 2.7.5 BGI Recent Developments and Future Plans
• 2.8 Zhiben Medical
  • 2.8.1 Zhiben Medical Details
  • 2.8.2 Zhiben Medical Major Business
  • 2.8.3 Zhiben Medical Molecular Residual Disease Detection Product and Solutions
  • 2.8.4 Zhiben Medical Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
  • 2.8.5 Zhiben Medical Recent Developments and Future Plans
• 2.9 Burning Rock Medicine
  • 2.9.1 Burning Rock Medicine Details
  • 2.9.2 Burning Rock Medicine Major Business
  • 2.9.3 Burning Rock Medicine Molecular Residual Disease Detection Product and Solutions
  • 2.9.4 Burning Rock Medicine Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
  • 2.9.5 Burning Rock Medicine Recent Developments and Future Plans
• 2.10 Huidu Medical
  • 2.10.1 Huidu Medical Details
  • 2.10.2 Huidu Medical Major Business
  • 2.10.3 Huidu Medical Molecular Residual Disease Detection Product and Solutions
  • 2.10.4 Huidu Medical Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
  • 2.10.5 Huidu Medical Recent Developments and Future Plans
• 2.11 Zhenhe Technology
  • 2.11.1 Zhenhe Technology Details
  • 2.11.2 Zhenhe Technology Major Business
  • 2.11.3 Zhenhe Technology Molecular Residual Disease Detection Product and Solutions
  • 2.11.4 Zhenhe Technology Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
  • 2.11.5 Zhenhe Technology Recent Developments and Future Plans
• 2.12 ExactSciences
  • 2.12.1 ExactSciences Details
  • 2.12.2 ExactSciences Major Business
  • 2.12.3 ExactSciences Molecular Residual Disease Detection Product and Solutions
  • 2.12.4 ExactSciences Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
  • 2.12.5 ExactSciences Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Molecular Residual Disease Detection Revenue and Share by Players (2018-2023)
• 3.2 Market Share Analysis (2022)
  • 3.2.1 Market Share of Molecular Residual Disease Detection by Company Revenue
  • 3.2.2 Top 3 Molecular Residual Disease Detection Players Market Share in 2022
  • 3.2.3 Top 6 Molecular Residual Disease Detection Players Market Share in 2022
• 3.3 Molecular Residual Disease Detection Market: Overall Company Footprint Analysis
  • 3.3.1 Molecular Residual Disease Detection Market: Region Footprint
  • 3.3.2 Molecular Residual Disease Detection Market: Company Product Type Footprint
  • 3.3.3 Molecular Residual Disease Detection Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global Molecular Residual Disease Detection Consumption Value and Market Share by Type (2018-2023)
• 4.2 Global Molecular Residual Disease Detection Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

• 5.1 Global Molecular Residual Disease Detection Consumption Value Market Share by Application (2018-2023)
• 5.2 Global Molecular Residual Disease Detection Market Forecast by Application (2024-2029)

6 North America

• 6.1 North America Molecular Residual Disease Detection Consumption Value by Type (2018-2029)
• 6.2 North America Molecular Residual Disease Detection Consumption Value by Application (2018-2029)
• 6.3 North America Molecular Residual Disease Detection Market Size by Country
  • 6.3.1 North America Molecular Residual Disease Detection Consumption Value by Country (2018-2029)
  • 6.3.2 United States Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
  • 6.3.3 Canada Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
  • 6.3.4 Mexico Molecular Residual Disease Detection Market Size and Forecast (2018-2029)

7 Europe

• 7.1 Europe Molecular Residual Disease Detection Consumption Value by Type (2018-2029)
• 7.2 Europe Molecular Residual Disease Detection Consumption Value by Application (2018-2029)
• 7.3 Europe Molecular Residual Disease Detection Market Size by Country
  • 7.3.1 Europe Molecular Residual Disease Detection Consumption Value by Country (2018-2029)
  • 7.3.2 Germany Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
  • 7.3.3 France Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
  • 7.3.4 United Kingdom Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
  • 7.3.5 Russia Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
  • 7.3.6 Italy Molecular Residual Disease Detection Market Size and Forecast (2018-2029)

8 Asia-Pacific

• 8.1 Asia-Pacific Molecular Residual Disease Detection Consumption Value by Type (2018-2029)
• 8.2 Asia-Pacific Molecular Residual Disease Detection Consumption Value by Application (2018-2029)
• 8.3 Asia-Pacific Molecular Residual Disease Detection Market Size by Region
  • 8.3.1 Asia-Pacific Molecular Residual Disease Detection Consumption Value by Region (2018-2029)
  • 8.3.2 China Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
  • 8.3.3 Japan Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
  • 8.3.4 South Korea Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
  • 8.3.5 India Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
  • 8.3.6 Southeast Asia Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
  • 8.3.7 Australia Molecular Residual Disease Detection Market Size and Forecast (2018-2029)

9 South America

• 9.1 South America Molecular Residual Disease Detection Consumption Value by Type (2018-2029)
• 9.2 South America Molecular Residual Disease Detection Consumption Value by Application (2018-2029)
• 9.3 South America Molecular Residual Disease Detection Market Size by Country
  • 9.3.1 South America Molecular Residual Disease Detection Consumption Value by Country (2018-2029)
  • 9.3.2 Brazil Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
  • 9.3.3 Argentina Molecular Residual Disease Detection Market Size and Forecast (2018-2029)

10 Middle East & Africa

• 10.1 Middle East & Africa Molecular Residual Disease Detection Consumption Value by Type (2018-2029)
• 10.2 Middle East & Africa Molecular Residual Disease Detection Consumption Value by Application (2018-2029)
• 10.3 Middle East & Africa Molecular Residual Disease Detection Market Size by Country
  • 10.3.1 Middle East & Africa Molecular Residual Disease Detection Consumption Value by Country (2018-2029)
  • 10.3.2 Turkey Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
  • 10.3.3 Saudi Arabia Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
  • 10.3.4 UAE Molecular Residual Disease Detection Market Size and Forecast (2018-2029)

11 Market Dynamics

• 11.1 Molecular Residual Disease Detection Market Drivers
• 11.2 Molecular Residual Disease Detection Market Restraints
• 11.3 Molecular Residual Disease Detection Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry
• 11.5 Influence of COVID-19 and Russia-Ukraine War
  • 11.5.1 Influence of COVID-19
  • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

• 12.1 Molecular Residual Disease Detection Industry Chain
• 12.2 Molecular Residual Disease Detection Upstream Analysis
• 12.3 Molecular Residual Disease Detection Midstream Analysis
• 12.4 Molecular Residual Disease Detection Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source